nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP3A7—Sorafenib—thyroid cancer	0.119	0.198	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.119	0.198	CbGbCtD
Nisoldipine—CYP3A5—Sorafenib—thyroid cancer	0.0892	0.149	CbGbCtD
Nisoldipine—CYP1A2—Sorafenib—thyroid cancer	0.0664	0.111	CbGbCtD
Nisoldipine—ABCB1—Sorafenib—thyroid cancer	0.058	0.0967	CbGbCtD
Nisoldipine—CYP3A4—Vandetanib—thyroid cancer	0.0577	0.0961	CbGbCtD
Nisoldipine—ABCB1—Doxorubicin—thyroid cancer	0.0352	0.0587	CbGbCtD
Nisoldipine—CYP3A4—Sorafenib—thyroid cancer	0.0348	0.0579	CbGbCtD
Nisoldipine—CYP3A4—Doxorubicin—thyroid cancer	0.0211	0.0352	CbGbCtD
Nisoldipine—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.00454	0.075	CbGpPWpGaD
Nisoldipine—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.00401	0.0663	CbGpPWpGaD
Nisoldipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.00202	0.0334	CbGpPWpGaD
Nisoldipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.00179	0.0295	CbGpPWpGaD
Nisoldipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.00173	0.0287	CbGpPWpGaD
Nisoldipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.00164	0.0271	CbGpPWpGaD
Nisoldipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.00153	0.0253	CbGpPWpGaD
Nisoldipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.00145	0.024	CbGpPWpGaD
Nisoldipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L1—thyroid cancer	0.00144	0.0239	CbGpPWpGaD
Nisoldipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—LAMA2—thyroid cancer	0.00127	0.0211	CbGpPWpGaD
Nisoldipine—Amblyopia—Doxorubicin—thyroid cancer	0.00127	0.00375	CcSEcCtD
Nisoldipine—Skin ulcer—Doxorubicin—thyroid cancer	0.00126	0.00372	CcSEcCtD
Nisoldipine—Otitis media—Doxorubicin—thyroid cancer	0.00126	0.00372	CcSEcCtD
Nisoldipine—Rash pustular—Doxorubicin—thyroid cancer	0.00123	0.00363	CcSEcCtD
Nisoldipine—Dysgeusia—Sorafenib—thyroid cancer	0.00123	0.00363	CcSEcCtD
Nisoldipine—Vasodilation procedure—Epirubicin—thyroid cancer	0.00121	0.00357	CcSEcCtD
Nisoldipine—Vasodilation—Epirubicin—thyroid cancer	0.00121	0.00357	CcSEcCtD
Nisoldipine—CACNB2—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00121	0.02	CbGpPWpGaD
Nisoldipine—Muscle spasms—Sorafenib—thyroid cancer	0.00121	0.00356	CcSEcCtD
Nisoldipine—Body temperature increased—Vandetanib—thyroid cancer	0.0012	0.00354	CcSEcCtD
Nisoldipine—Petechiae—Doxorubicin—thyroid cancer	0.0012	0.00352	CcSEcCtD
Nisoldipine—Skin discolouration—Epirubicin—thyroid cancer	0.00118	0.00347	CcSEcCtD
Nisoldipine—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00118	0.00347	CcSEcCtD
Nisoldipine—Cellulitis—Epirubicin—thyroid cancer	0.00117	0.00344	CcSEcCtD
Nisoldipine—Anaemia—Sorafenib—thyroid cancer	0.00116	0.00342	CcSEcCtD
Nisoldipine—Thinking abnormal—Epirubicin—thyroid cancer	0.00116	0.00342	CcSEcCtD
Nisoldipine—Cough increased—Epirubicin—thyroid cancer	0.00116	0.00342	CcSEcCtD
Nisoldipine—Glossitis—Epirubicin—thyroid cancer	0.00115	0.0034	CcSEcCtD
Nisoldipine—Herpes simplex—Epirubicin—thyroid cancer	0.00115	0.0034	CcSEcCtD
Nisoldipine—Lacrimation increased—Epirubicin—thyroid cancer	0.00115	0.0034	CcSEcCtD
Nisoldipine—Angioedema—Sorafenib—thyroid cancer	0.00115	0.00339	CcSEcCtD
Nisoldipine—Nocturia—Epirubicin—thyroid cancer	0.00115	0.00338	CcSEcCtD
Nisoldipine—CACNA1D—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00115	0.0189	CbGpPWpGaD
Nisoldipine—Syncope—Sorafenib—thyroid cancer	0.00113	0.00332	CcSEcCtD
Nisoldipine—Leukopenia—Sorafenib—thyroid cancer	0.00113	0.00332	CcSEcCtD
Nisoldipine—Vasodilation procedure—Doxorubicin—thyroid cancer	0.00112	0.0033	CcSEcCtD
Nisoldipine—Vasodilation—Doxorubicin—thyroid cancer	0.00112	0.0033	CcSEcCtD
Nisoldipine—Loss of consciousness—Sorafenib—thyroid cancer	0.00111	0.00326	CcSEcCtD
Nisoldipine—Cough—Sorafenib—thyroid cancer	0.0011	0.00323	CcSEcCtD
Nisoldipine—Skin discolouration—Doxorubicin—thyroid cancer	0.00109	0.00321	CcSEcCtD
Nisoldipine—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00109	0.00321	CcSEcCtD
Nisoldipine—Cellulitis—Doxorubicin—thyroid cancer	0.00108	0.00319	CcSEcCtD
Nisoldipine—Pruritus—Vandetanib—thyroid cancer	0.00108	0.00317	CcSEcCtD
Nisoldipine—Thinking abnormal—Doxorubicin—thyroid cancer	0.00107	0.00317	CcSEcCtD
Nisoldipine—Cough increased—Doxorubicin—thyroid cancer	0.00107	0.00317	CcSEcCtD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—CDK1—thyroid cancer	0.00107	0.0177	CbGpPWpGaD
Nisoldipine—Arthralgia—Sorafenib—thyroid cancer	0.00107	0.00315	CcSEcCtD
Nisoldipine—Myalgia—Sorafenib—thyroid cancer	0.00107	0.00315	CcSEcCtD
Nisoldipine—Glossitis—Doxorubicin—thyroid cancer	0.00107	0.00315	CcSEcCtD
Nisoldipine—Herpes simplex—Doxorubicin—thyroid cancer	0.00107	0.00315	CcSEcCtD
Nisoldipine—Lacrimation increased—Doxorubicin—thyroid cancer	0.00107	0.00315	CcSEcCtD
Nisoldipine—Vaginal inflammation—Epirubicin—thyroid cancer	0.00106	0.00313	CcSEcCtD
Nisoldipine—Nocturia—Doxorubicin—thyroid cancer	0.00106	0.00312	CcSEcCtD
Nisoldipine—Abnormal dreams—Epirubicin—thyroid cancer	0.00105	0.0031	CcSEcCtD
Nisoldipine—Dry mouth—Sorafenib—thyroid cancer	0.00105	0.00309	CcSEcCtD
Nisoldipine—Diarrhoea—Vandetanib—thyroid cancer	0.00104	0.00307	CcSEcCtD
Nisoldipine—Melaena—Epirubicin—thyroid cancer	0.00104	0.00306	CcSEcCtD
Nisoldipine—Colitis—Epirubicin—thyroid cancer	0.00102	0.00301	CcSEcCtD
Nisoldipine—Shock—Sorafenib—thyroid cancer	0.00101	0.00298	CcSEcCtD
Nisoldipine—CACNA1C—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00101	0.0166	CbGpPWpGaD
Nisoldipine—Dizziness—Vandetanib—thyroid cancer	0.00101	0.00296	CcSEcCtD
Nisoldipine—Vaginal infection—Epirubicin—thyroid cancer	0.001	0.00296	CcSEcCtD
Nisoldipine—Blood urea increased—Epirubicin—thyroid cancer	0.001	0.00296	CcSEcCtD
Nisoldipine—Vaginal inflammation—Doxorubicin—thyroid cancer	0.000984	0.0029	CcSEcCtD
Nisoldipine—Anorexia—Sorafenib—thyroid cancer	0.000978	0.00288	CcSEcCtD
Nisoldipine—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000977	0.00288	CcSEcCtD
Nisoldipine—Abnormal dreams—Doxorubicin—thyroid cancer	0.000972	0.00286	CcSEcCtD
Nisoldipine—Rash maculo-papular—Epirubicin—thyroid cancer	0.000966	0.00285	CcSEcCtD
Nisoldipine—Mouth ulceration—Epirubicin—thyroid cancer	0.000961	0.00283	CcSEcCtD
Nisoldipine—Ecchymosis—Epirubicin—thyroid cancer	0.000961	0.00283	CcSEcCtD
Nisoldipine—Melaena—Doxorubicin—thyroid cancer	0.000961	0.00283	CcSEcCtD
Nisoldipine—Rash—Vandetanib—thyroid cancer	0.000959	0.00283	CcSEcCtD
Nisoldipine—Dermatitis—Vandetanib—thyroid cancer	0.000959	0.00282	CcSEcCtD
Nisoldipine—Headache—Vandetanib—thyroid cancer	0.000953	0.00281	CcSEcCtD
Nisoldipine—CACNB2—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.000951	0.0157	CbGpPWpGaD
Nisoldipine—Colitis—Doxorubicin—thyroid cancer	0.000945	0.00278	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000935	0.00276	CcSEcCtD
Nisoldipine—Hypertonia—Epirubicin—thyroid cancer	0.000932	0.00275	CcSEcCtD
Nisoldipine—Blood urea increased—Doxorubicin—thyroid cancer	0.000929	0.00274	CcSEcCtD
Nisoldipine—Vaginal infection—Doxorubicin—thyroid cancer	0.000929	0.00274	CcSEcCtD
Nisoldipine—Abnormal vision—Epirubicin—thyroid cancer	0.000927	0.00273	CcSEcCtD
Nisoldipine—Mental disability—Epirubicin—thyroid cancer	0.000923	0.00272	CcSEcCtD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—CDK1—thyroid cancer	0.00092	0.0152	CbGpPWpGaD
Nisoldipine—Dyspnoea—Sorafenib—thyroid cancer	0.000915	0.0027	CcSEcCtD
Nisoldipine—Nausea—Vandetanib—thyroid cancer	0.000904	0.00266	CcSEcCtD
Nisoldipine—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000904	0.00266	CcSEcCtD
Nisoldipine—Dyspepsia—Sorafenib—thyroid cancer	0.000904	0.00266	CcSEcCtD
Nisoldipine—CACNA1D—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.000901	0.0149	CbGpPWpGaD
Nisoldipine—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000894	0.00263	CcSEcCtD
Nisoldipine—Decreased appetite—Sorafenib—thyroid cancer	0.000892	0.00263	CcSEcCtD
Nisoldipine—Ecchymosis—Doxorubicin—thyroid cancer	0.00089	0.00262	CcSEcCtD
Nisoldipine—Mouth ulceration—Doxorubicin—thyroid cancer	0.00089	0.00262	CcSEcCtD
Nisoldipine—Diabetes mellitus—Epirubicin—thyroid cancer	0.000887	0.00261	CcSEcCtD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—CDK1—thyroid cancer	0.000871	0.0144	CbGpPWpGaD
Nisoldipine—Hypertonia—Doxorubicin—thyroid cancer	0.000862	0.00254	CcSEcCtD
Nisoldipine—Abnormal vision—Doxorubicin—thyroid cancer	0.000858	0.00253	CcSEcCtD
Nisoldipine—Mental disability—Doxorubicin—thyroid cancer	0.000854	0.00252	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000851	0.00251	CcSEcCtD
Nisoldipine—CACNA1S—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.000832	0.0138	CbGpPWpGaD
Nisoldipine—Increased appetite—Epirubicin—thyroid cancer	0.000822	0.00242	CcSEcCtD
Nisoldipine—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000821	0.00242	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000818	0.00241	CcSEcCtD
Nisoldipine—Urticaria—Sorafenib—thyroid cancer	0.000815	0.0024	CcSEcCtD
Nisoldipine—Body temperature increased—Sorafenib—thyroid cancer	0.000811	0.00239	CcSEcCtD
Nisoldipine—CACNA1C—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.000791	0.0131	CbGpPWpGaD
Nisoldipine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000788	0.00232	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000788	0.00232	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000772	0.00227	CcSEcCtD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—CDK1—thyroid cancer	0.000766	0.0127	CbGpPWpGaD
Nisoldipine—Increased appetite—Doxorubicin—thyroid cancer	0.00076	0.00224	CcSEcCtD
Nisoldipine—Migraine—Epirubicin—thyroid cancer	0.00076	0.00224	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000757	0.00223	CcSEcCtD
Nisoldipine—Hypersensitivity—Sorafenib—thyroid cancer	0.000756	0.00223	CcSEcCtD
Nisoldipine—Face oedema—Epirubicin—thyroid cancer	0.000745	0.0022	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000729	0.00215	CcSEcCtD
Nisoldipine—Pruritus—Sorafenib—thyroid cancer	0.000726	0.00214	CcSEcCtD
Nisoldipine—Ataxia—Epirubicin—thyroid cancer	0.000726	0.00214	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000714	0.0021	CcSEcCtD
Nisoldipine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000713	0.0021	CcSEcCtD
Nisoldipine—Dry skin—Epirubicin—thyroid cancer	0.000708	0.00208	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000705	0.00208	CcSEcCtD
Nisoldipine—Migraine—Doxorubicin—thyroid cancer	0.000703	0.00207	CcSEcCtD
Nisoldipine—Hypokalaemia—Epirubicin—thyroid cancer	0.000702	0.00207	CcSEcCtD
Nisoldipine—Diarrhoea—Sorafenib—thyroid cancer	0.000702	0.00207	CcSEcCtD
Nisoldipine—CYP3A7—Metapathway biotransformation—CHST14—thyroid cancer	0.000702	0.0116	CbGpPWpGaD
Nisoldipine—Face oedema—Doxorubicin—thyroid cancer	0.000689	0.00203	CcSEcCtD
Nisoldipine—Gastritis—Epirubicin—thyroid cancer	0.000683	0.00201	CcSEcCtD
Nisoldipine—Muscular weakness—Epirubicin—thyroid cancer	0.000681	0.00201	CcSEcCtD
Nisoldipine—Dizziness—Sorafenib—thyroid cancer	0.000679	0.002	CcSEcCtD
Nisoldipine—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000678	0.0112	CbGpPWpGaD
Nisoldipine—CACNA1D—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.000676	0.0112	CbGpPWpGaD
Nisoldipine—Ataxia—Doxorubicin—thyroid cancer	0.000672	0.00198	CcSEcCtD
Nisoldipine—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000671	0.0111	CbGpPWpGaD
Nisoldipine—Asthma—Epirubicin—thyroid cancer	0.000667	0.00197	CcSEcCtD
Nisoldipine—Dysphagia—Epirubicin—thyroid cancer	0.000667	0.00197	CcSEcCtD
Nisoldipine—Influenza—Epirubicin—thyroid cancer	0.000667	0.00197	CcSEcCtD
Nisoldipine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000659	0.00194	CcSEcCtD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000656	0.0108	CbGpPWpGaD
Nisoldipine—Dry skin—Doxorubicin—thyroid cancer	0.000655	0.00193	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000652	0.00192	CcSEcCtD
Nisoldipine—Hypokalaemia—Doxorubicin—thyroid cancer	0.00065	0.00191	CcSEcCtD
Nisoldipine—Rash—Sorafenib—thyroid cancer	0.000647	0.00191	CcSEcCtD
Nisoldipine—Dermatitis—Sorafenib—thyroid cancer	0.000647	0.0019	CcSEcCtD
Nisoldipine—Headache—Sorafenib—thyroid cancer	0.000643	0.00189	CcSEcCtD
Nisoldipine—Gastritis—Doxorubicin—thyroid cancer	0.000632	0.00186	CcSEcCtD
Nisoldipine—Muscular weakness—Doxorubicin—thyroid cancer	0.00063	0.00186	CcSEcCtD
Nisoldipine—Dysuria—Epirubicin—thyroid cancer	0.000624	0.00184	CcSEcCtD
Nisoldipine—Asthma—Doxorubicin—thyroid cancer	0.000617	0.00182	CcSEcCtD
Nisoldipine—Influenza—Doxorubicin—thyroid cancer	0.000617	0.00182	CcSEcCtD
Nisoldipine—Dysphagia—Doxorubicin—thyroid cancer	0.000617	0.00182	CcSEcCtD
Nisoldipine—Pollakiuria—Epirubicin—thyroid cancer	0.000616	0.00182	CcSEcCtD
Nisoldipine—Nausea—Sorafenib—thyroid cancer	0.00061	0.0018	CcSEcCtD
Nisoldipine—Weight increased—Epirubicin—thyroid cancer	0.000607	0.00179	CcSEcCtD
Nisoldipine—Weight decreased—Epirubicin—thyroid cancer	0.000604	0.00178	CcSEcCtD
Nisoldipine—CACNA1C—Calcium Regulation in the Cardiac Cell—PRKAR1A—thyroid cancer	0.000594	0.00981	CbGpPWpGaD
Nisoldipine—Stomatitis—Epirubicin—thyroid cancer	0.00058	0.00171	CcSEcCtD
Nisoldipine—Conjunctivitis—Epirubicin—thyroid cancer	0.000578	0.0017	CcSEcCtD
Nisoldipine—Dysuria—Doxorubicin—thyroid cancer	0.000577	0.0017	CcSEcCtD
Nisoldipine—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000575	0.0095	CbGpPWpGaD
Nisoldipine—Sweating—Epirubicin—thyroid cancer	0.00057	0.00168	CcSEcCtD
Nisoldipine—Pollakiuria—Doxorubicin—thyroid cancer	0.00057	0.00168	CcSEcCtD
Nisoldipine—Haematuria—Epirubicin—thyroid cancer	0.000567	0.00167	CcSEcCtD
Nisoldipine—Weight increased—Doxorubicin—thyroid cancer	0.000562	0.00165	CcSEcCtD
Nisoldipine—Epistaxis—Epirubicin—thyroid cancer	0.000561	0.00165	CcSEcCtD
Nisoldipine—Weight decreased—Doxorubicin—thyroid cancer	0.000558	0.00165	CcSEcCtD
Nisoldipine—Sinusitis—Epirubicin—thyroid cancer	0.000558	0.00164	CcSEcCtD
Nisoldipine—Stomatitis—Doxorubicin—thyroid cancer	0.000536	0.00158	CcSEcCtD
Nisoldipine—Rhinitis—Epirubicin—thyroid cancer	0.000535	0.00158	CcSEcCtD
Nisoldipine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000535	0.00158	CcSEcCtD
Nisoldipine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000531	0.00157	CcSEcCtD
Nisoldipine—Pharyngitis—Epirubicin—thyroid cancer	0.00053	0.00156	CcSEcCtD
Nisoldipine—Sweating—Doxorubicin—thyroid cancer	0.000528	0.00155	CcSEcCtD
Nisoldipine—Oedema peripheral—Epirubicin—thyroid cancer	0.000526	0.00155	CcSEcCtD
Nisoldipine—Haematuria—Doxorubicin—thyroid cancer	0.000525	0.00155	CcSEcCtD
Nisoldipine—Epistaxis—Doxorubicin—thyroid cancer	0.000519	0.00153	CcSEcCtD
Nisoldipine—Sinusitis—Doxorubicin—thyroid cancer	0.000516	0.00152	CcSEcCtD
Nisoldipine—Visual impairment—Epirubicin—thyroid cancer	0.000515	0.00152	CcSEcCtD
Nisoldipine—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	0.000507	0.00838	CbGpPWpGaD
Nisoldipine—Tinnitus—Epirubicin—thyroid cancer	0.000498	0.00147	CcSEcCtD
Nisoldipine—Rhinitis—Doxorubicin—thyroid cancer	0.000495	0.00146	CcSEcCtD
Nisoldipine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000492	0.00145	CcSEcCtD
Nisoldipine—Pharyngitis—Doxorubicin—thyroid cancer	0.00049	0.00144	CcSEcCtD
Nisoldipine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000487	0.00143	CcSEcCtD
Nisoldipine—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000481	0.00795	CbGpPWpGaD
Nisoldipine—Chills—Epirubicin—thyroid cancer	0.000479	0.00141	CcSEcCtD
Nisoldipine—Visual impairment—Doxorubicin—thyroid cancer	0.000476	0.0014	CcSEcCtD
Nisoldipine—Alopecia—Epirubicin—thyroid cancer	0.000472	0.00139	CcSEcCtD
Nisoldipine—Tinnitus—Doxorubicin—thyroid cancer	0.000461	0.00136	CcSEcCtD
Nisoldipine—Flatulence—Epirubicin—thyroid cancer	0.000458	0.00135	CcSEcCtD
Nisoldipine—Tension—Epirubicin—thyroid cancer	0.000456	0.00134	CcSEcCtD
Nisoldipine—Dysgeusia—Epirubicin—thyroid cancer	0.000455	0.00134	CcSEcCtD
Nisoldipine—Nervousness—Epirubicin—thyroid cancer	0.000451	0.00133	CcSEcCtD
Nisoldipine—Muscle spasms—Epirubicin—thyroid cancer	0.000447	0.00132	CcSEcCtD
Nisoldipine—Chills—Doxorubicin—thyroid cancer	0.000443	0.00131	CcSEcCtD
Nisoldipine—Alopecia—Doxorubicin—thyroid cancer	0.000437	0.00129	CcSEcCtD
Nisoldipine—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000434	0.00717	CbGpPWpGaD
Nisoldipine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000431	0.00127	CcSEcCtD
Nisoldipine—Anaemia—Epirubicin—thyroid cancer	0.00043	0.00127	CcSEcCtD
Nisoldipine—Flatulence—Doxorubicin—thyroid cancer	0.000424	0.00125	CcSEcCtD
Nisoldipine—Tension—Doxorubicin—thyroid cancer	0.000422	0.00124	CcSEcCtD
Nisoldipine—Dysgeusia—Doxorubicin—thyroid cancer	0.000421	0.00124	CcSEcCtD
Nisoldipine—Malaise—Epirubicin—thyroid cancer	0.000419	0.00123	CcSEcCtD
Nisoldipine—Nervousness—Doxorubicin—thyroid cancer	0.000418	0.00123	CcSEcCtD
Nisoldipine—Vertigo—Epirubicin—thyroid cancer	0.000418	0.00123	CcSEcCtD
Nisoldipine—Syncope—Epirubicin—thyroid cancer	0.000417	0.00123	CcSEcCtD
Nisoldipine—Leukopenia—Epirubicin—thyroid cancer	0.000416	0.00123	CcSEcCtD
Nisoldipine—Muscle spasms—Doxorubicin—thyroid cancer	0.000414	0.00122	CcSEcCtD
Nisoldipine—Palpitations—Epirubicin—thyroid cancer	0.000411	0.00121	CcSEcCtD
Nisoldipine—Loss of consciousness—Epirubicin—thyroid cancer	0.000409	0.0012	CcSEcCtD
Nisoldipine—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000406	0.0067	CbGpPWpGaD
Nisoldipine—Cough—Epirubicin—thyroid cancer	0.000406	0.00119	CcSEcCtD
Nisoldipine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000399	0.00118	CcSEcCtD
Nisoldipine—Anaemia—Doxorubicin—thyroid cancer	0.000398	0.00117	CcSEcCtD
Nisoldipine—Arthralgia—Epirubicin—thyroid cancer	0.000396	0.00117	CcSEcCtD
Nisoldipine—Chest pain—Epirubicin—thyroid cancer	0.000396	0.00117	CcSEcCtD
Nisoldipine—Myalgia—Epirubicin—thyroid cancer	0.000396	0.00117	CcSEcCtD
Nisoldipine—Anxiety—Epirubicin—thyroid cancer	0.000394	0.00116	CcSEcCtD
Nisoldipine—Discomfort—Epirubicin—thyroid cancer	0.000391	0.00115	CcSEcCtD
Nisoldipine—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00039	0.00645	CbGpPWpGaD
Nisoldipine—Malaise—Doxorubicin—thyroid cancer	0.000388	0.00114	CcSEcCtD
Nisoldipine—Dry mouth—Epirubicin—thyroid cancer	0.000387	0.00114	CcSEcCtD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000387	0.00639	CbGpPWpGaD
Nisoldipine—Vertigo—Doxorubicin—thyroid cancer	0.000386	0.00114	CcSEcCtD
Nisoldipine—Syncope—Doxorubicin—thyroid cancer	0.000386	0.00114	CcSEcCtD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—NRAS—thyroid cancer	0.000385	0.00636	CbGpPWpGaD
Nisoldipine—Leukopenia—Doxorubicin—thyroid cancer	0.000385	0.00113	CcSEcCtD
Nisoldipine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000385	0.00636	CbGpPWpGaD
Nisoldipine—Confusional state—Epirubicin—thyroid cancer	0.000383	0.00113	CcSEcCtD
Nisoldipine—Palpitations—Doxorubicin—thyroid cancer	0.00038	0.00112	CcSEcCtD
Nisoldipine—Oedema—Epirubicin—thyroid cancer	0.000379	0.00112	CcSEcCtD
Nisoldipine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000378	0.00111	CcSEcCtD
Nisoldipine—Cough—Doxorubicin—thyroid cancer	0.000375	0.00111	CcSEcCtD
Nisoldipine—Shock—Epirubicin—thyroid cancer	0.000373	0.0011	CcSEcCtD
Nisoldipine—Tachycardia—Epirubicin—thyroid cancer	0.00037	0.00109	CcSEcCtD
Nisoldipine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000367	0.00108	CcSEcCtD
Nisoldipine—Chest pain—Doxorubicin—thyroid cancer	0.000366	0.00108	CcSEcCtD
Nisoldipine—Myalgia—Doxorubicin—thyroid cancer	0.000366	0.00108	CcSEcCtD
Nisoldipine—Arthralgia—Doxorubicin—thyroid cancer	0.000366	0.00108	CcSEcCtD
Nisoldipine—Anxiety—Doxorubicin—thyroid cancer	0.000365	0.00107	CcSEcCtD
Nisoldipine—Discomfort—Doxorubicin—thyroid cancer	0.000362	0.00107	CcSEcCtD
Nisoldipine—Anorexia—Epirubicin—thyroid cancer	0.000362	0.00107	CcSEcCtD
Nisoldipine—Dry mouth—Doxorubicin—thyroid cancer	0.000358	0.00105	CcSEcCtD
Nisoldipine—Hypotension—Epirubicin—thyroid cancer	0.000354	0.00104	CcSEcCtD
Nisoldipine—Confusional state—Doxorubicin—thyroid cancer	0.000354	0.00104	CcSEcCtD
Nisoldipine—Oedema—Doxorubicin—thyroid cancer	0.000351	0.00103	CcSEcCtD
Nisoldipine—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000348	0.00575	CbGpPWpGaD
Nisoldipine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000346	0.00102	CcSEcCtD
Nisoldipine—Shock—Doxorubicin—thyroid cancer	0.000345	0.00102	CcSEcCtD
Nisoldipine—Insomnia—Epirubicin—thyroid cancer	0.000343	0.00101	CcSEcCtD
Nisoldipine—Tachycardia—Doxorubicin—thyroid cancer	0.000343	0.00101	CcSEcCtD
Nisoldipine—Paraesthesia—Epirubicin—thyroid cancer	0.000341	0.001	CcSEcCtD
Nisoldipine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000339	0.001	CcSEcCtD
Nisoldipine—Dyspnoea—Epirubicin—thyroid cancer	0.000338	0.000996	CcSEcCtD
Nisoldipine—Somnolence—Epirubicin—thyroid cancer	0.000337	0.000994	CcSEcCtD
Nisoldipine—Anorexia—Doxorubicin—thyroid cancer	0.000335	0.000986	CcSEcCtD
Nisoldipine—Dyspepsia—Epirubicin—thyroid cancer	0.000334	0.000984	CcSEcCtD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—KRAS—thyroid cancer	0.000331	0.00548	CbGpPWpGaD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—NRAS—thyroid cancer	0.00033	0.00546	CbGpPWpGaD
Nisoldipine—Decreased appetite—Epirubicin—thyroid cancer	0.00033	0.000971	CcSEcCtD
Nisoldipine—Hypotension—Doxorubicin—thyroid cancer	0.000328	0.000966	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00032	0.000942	CcSEcCtD
Nisoldipine—Insomnia—Doxorubicin—thyroid cancer	0.000317	0.000935	CcSEcCtD
Nisoldipine—Paraesthesia—Doxorubicin—thyroid cancer	0.000315	0.000929	CcSEcCtD
Nisoldipine—Dyspnoea—Doxorubicin—thyroid cancer	0.000313	0.000922	CcSEcCtD
Nisoldipine—Feeling abnormal—Epirubicin—thyroid cancer	0.000313	0.000921	CcSEcCtD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—NRAS—thyroid cancer	0.000313	0.00517	CbGpPWpGaD
Nisoldipine—Somnolence—Doxorubicin—thyroid cancer	0.000312	0.000919	CcSEcCtD
Nisoldipine—Dyspepsia—Doxorubicin—thyroid cancer	0.000309	0.00091	CcSEcCtD
Nisoldipine—CACNA1S—Axon guidance—CDK1—thyroid cancer	0.000308	0.00509	CbGpPWpGaD
Nisoldipine—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000306	0.00505	CbGpPWpGaD
Nisoldipine—Decreased appetite—Doxorubicin—thyroid cancer	0.000305	0.000899	CcSEcCtD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000303	0.00501	CbGpPWpGaD
Nisoldipine—Urticaria—Epirubicin—thyroid cancer	0.000301	0.000888	CcSEcCtD
Nisoldipine—Body temperature increased—Epirubicin—thyroid cancer	0.0003	0.000883	CcSEcCtD
Nisoldipine—CACNB2—Metabolism—MINPP1—thyroid cancer	0.000299	0.00494	CbGpPWpGaD
Nisoldipine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000289	0.000852	CcSEcCtD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—KRAS—thyroid cancer	0.000284	0.0047	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—MINPP1—thyroid cancer	0.000283	0.00468	CbGpPWpGaD
Nisoldipine—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000282	0.00466	CbGpPWpGaD
Nisoldipine—CACNA1S—NCAM signaling for neurite out-growth—HRAS—thyroid cancer	0.000282	0.00466	CbGpPWpGaD
Nisoldipine—Hypersensitivity—Epirubicin—thyroid cancer	0.00028	0.000823	CcSEcCtD
Nisoldipine—Urticaria—Doxorubicin—thyroid cancer	0.000279	0.000821	CcSEcCtD
Nisoldipine—Body temperature increased—Doxorubicin—thyroid cancer	0.000277	0.000817	CcSEcCtD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—NRAS—thyroid cancer	0.000275	0.00454	CbGpPWpGaD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—KRAS—thyroid cancer	0.000269	0.00445	CbGpPWpGaD
Nisoldipine—Pruritus—Epirubicin—thyroid cancer	0.000268	0.000791	CcSEcCtD
Nisoldipine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000267	0.00442	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—CDK1—thyroid cancer	0.000264	0.00436	CbGpPWpGaD
Nisoldipine—CACNA1S—Alzheimers Disease—TP53—thyroid cancer	0.000261	0.00432	CbGpPWpGaD
Nisoldipine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000261	0.00431	CbGpPWpGaD
Nisoldipine—Diarrhoea—Epirubicin—thyroid cancer	0.00026	0.000765	CcSEcCtD
Nisoldipine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000259	0.000762	CcSEcCtD
Nisoldipine—CACNB2—Metabolism—NDUFA13—thyroid cancer	0.000254	0.0042	CbGpPWpGaD
Nisoldipine—Dizziness—Epirubicin—thyroid cancer	0.000251	0.000739	CcSEcCtD
Nisoldipine—CACNA1D—Axon guidance—CDK1—thyroid cancer	0.00025	0.00413	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—MINPP1—thyroid cancer	0.000249	0.00411	CbGpPWpGaD
Nisoldipine—Pruritus—Doxorubicin—thyroid cancer	0.000248	0.000732	CcSEcCtD
Nisoldipine—CACNB2—NCAM signaling for neurite out-growth—HRAS—thyroid cancer	0.000241	0.00399	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—NDUFA13—thyroid cancer	0.000241	0.00398	CbGpPWpGaD
Nisoldipine—Diarrhoea—Doxorubicin—thyroid cancer	0.00024	0.000708	CcSEcCtD
Nisoldipine—Rash—Epirubicin—thyroid cancer	0.000239	0.000705	CcSEcCtD
Nisoldipine—Dermatitis—Epirubicin—thyroid cancer	0.000239	0.000704	CcSEcCtD
Nisoldipine—CACNB2—Metabolism—CHST14—thyroid cancer	0.000239	0.00395	CbGpPWpGaD
Nisoldipine—Headache—Epirubicin—thyroid cancer	0.000238	0.0007	CcSEcCtD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—KRAS—thyroid cancer	0.000236	0.00391	CbGpPWpGaD
Nisoldipine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000236	0.0039	CbGpPWpGaD
Nisoldipine—Dizziness—Doxorubicin—thyroid cancer	0.000232	0.000684	CcSEcCtD
Nisoldipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—thyroid cancer	0.000229	0.00378	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CHST14—thyroid cancer	0.000226	0.00374	CbGpPWpGaD
Nisoldipine—Nausea—Epirubicin—thyroid cancer	0.000225	0.000664	CcSEcCtD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000222	0.00366	CbGpPWpGaD
Nisoldipine—Rash—Doxorubicin—thyroid cancer	0.000221	0.000652	CcSEcCtD
Nisoldipine—Dermatitis—Doxorubicin—thyroid cancer	0.000221	0.000651	CcSEcCtD
Nisoldipine—Headache—Doxorubicin—thyroid cancer	0.00022	0.000648	CcSEcCtD
Nisoldipine—CACNA1S—Developmental Biology—CDK1—thyroid cancer	0.00022	0.00363	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—CDK1—thyroid cancer	0.00022	0.00363	CbGpPWpGaD
Nisoldipine—CACNA1D—Alzheimers Disease—TP53—thyroid cancer	0.000212	0.00351	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—NDUFA13—thyroid cancer	0.000211	0.00349	CbGpPWpGaD
Nisoldipine—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000209	0.00346	CbGpPWpGaD
Nisoldipine—Nausea—Doxorubicin—thyroid cancer	0.000209	0.000614	CcSEcCtD
Nisoldipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000208	0.00344	CbGpPWpGaD
Nisoldipine—CYP3A7—Biological oxidations—RXRA—thyroid cancer	0.000207	0.00342	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—RXRA—thyroid cancer	0.000204	0.00337	CbGpPWpGaD
Nisoldipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—thyroid cancer	0.000201	0.00332	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CHST14—thyroid cancer	0.000199	0.00328	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—HPGD—thyroid cancer	0.000192	0.00318	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000189	0.00312	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—CDK1—thyroid cancer	0.000188	0.00311	CbGpPWpGaD
Nisoldipine—CACNA1C—Alzheimers Disease—TP53—thyroid cancer	0.000186	0.00308	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—HPGD—thyroid cancer	0.000182	0.00301	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000181	0.00298	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—CDK1—thyroid cancer	0.000178	0.00295	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—RXRA—thyroid cancer	0.000175	0.00289	CbGpPWpGaD
Nisoldipine—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00017	0.00281	CbGpPWpGaD
Nisoldipine—CACNB2—Neuronal System—BRAF—thyroid cancer	0.00017	0.00281	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—RXRA—thyroid cancer	0.000166	0.00274	CbGpPWpGaD
Nisoldipine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000162	0.00267	CbGpPWpGaD
Nisoldipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000161	0.00266	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—HPGD—thyroid cancer	0.00016	0.00265	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—CDK1—thyroid cancer	0.000157	0.00259	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—MINPP1—thyroid cancer	0.000152	0.00252	CbGpPWpGaD
Nisoldipine—CYP3A5—Biological oxidations—RXRA—thyroid cancer	0.00015	0.00248	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—RXRA—thyroid cancer	0.000145	0.0024	CbGpPWpGaD
Nisoldipine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000131	0.00217	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NDUFA13—thyroid cancer	0.000129	0.00214	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—PPARG—thyroid cancer	0.000129	0.00213	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000129	0.00213	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CHST14—thyroid cancer	0.000122	0.00201	CbGpPWpGaD
Nisoldipine—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.00012	0.00199	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—TPR—thyroid cancer	0.000111	0.00183	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—NRAS—thyroid cancer	0.00011	0.00183	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—PPARG—thyroid cancer	0.00011	0.00182	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—MINPP1—thyroid cancer	0.00011	0.00182	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PRKAR1A—thyroid cancer	0.000109	0.0018	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—TPR—thyroid cancer	0.000105	0.00173	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—PPARG—thyroid cancer	0.000105	0.00173	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000104	0.00172	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PRKAR1A—thyroid cancer	0.000103	0.0017	CbGpPWpGaD
Nisoldipine—CACNB2—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000102	0.00168	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.0001	0.00166	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—HPGD—thyroid cancer	9.81e-05	0.00162	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	9.59e-05	0.00158	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—KRAS—thyroid cancer	9.5e-05	0.00157	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—NRAS—thyroid cancer	9.47e-05	0.00156	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NDUFA13—thyroid cancer	9.35e-05	0.00155	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—TPR—thyroid cancer	9.2e-05	0.00152	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—PPARG—thyroid cancer	9.18e-05	0.00152	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PRKAR1A—thyroid cancer	9.05e-05	0.0015	CbGpPWpGaD
Nisoldipine—CYP1A2—Biological oxidations—RXRA—thyroid cancer	9.02e-05	0.00149	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—NRAS—thyroid cancer	8.97e-05	0.00148	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CHST14—thyroid cancer	8.79e-05	0.00145	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	8.62e-05	0.00142	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—MINPP1—thyroid cancer	8.3e-05	0.00137	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—SLC5A5—thyroid cancer	8.28e-05	0.00137	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—KRAS—thyroid cancer	8.15e-05	0.00135	CbGpPWpGaD
Nisoldipine—CACNA1S—Axon guidance—HRAS—thyroid cancer	8.08e-05	0.00134	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—NRAS—thyroid cancer	7.88e-05	0.0013	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—NRAS—thyroid cancer	7.88e-05	0.0013	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—SLC5A5—thyroid cancer	7.84e-05	0.0013	CbGpPWpGaD
Nisoldipine—CACNB2—Neuronal System—HRAS—thyroid cancer	7.81e-05	0.00129	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—KRAS—thyroid cancer	7.72e-05	0.00128	CbGpPWpGaD
Nisoldipine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	7.32e-05	0.00121	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—HPGD—thyroid cancer	7.09e-05	0.00117	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NDUFA13—thyroid cancer	7.06e-05	0.00117	CbGpPWpGaD
Nisoldipine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.96e-05	0.00115	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—RXRA—thyroid cancer	6.95e-05	0.00115	CbGpPWpGaD
Nisoldipine—CACNB2—Axon guidance—HRAS—thyroid cancer	6.93e-05	0.00114	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—SLC5A5—thyroid cancer	6.89e-05	0.00114	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—KRAS—thyroid cancer	6.78e-05	0.00112	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—KRAS—thyroid cancer	6.78e-05	0.00112	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—NRAS—thyroid cancer	6.76e-05	0.00112	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CHST14—thyroid cancer	6.64e-05	0.0011	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—MINPP1—thyroid cancer	6.63e-05	0.0011	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—RXRA—thyroid cancer	6.58e-05	0.00109	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	6.56e-05	0.00108	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	6.56e-05	0.00108	CbGpPWpGaD
Nisoldipine—CACNA1D—Axon guidance—HRAS—thyroid cancer	6.56e-05	0.00108	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	6.45e-05	0.00107	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—NRAS—thyroid cancer	6.4e-05	0.00106	CbGpPWpGaD
Nisoldipine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	6.07e-05	0.001	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—KRAS—thyroid cancer	5.81e-05	0.000961	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—RXRA—thyroid cancer	5.79e-05	0.000956	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—HRAS—thyroid cancer	5.76e-05	0.000953	CbGpPWpGaD
Nisoldipine—CACNA1C—Axon guidance—HRAS—thyroid cancer	5.76e-05	0.000953	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	5.63e-05	0.000931	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—TPR—thyroid cancer	5.63e-05	0.000931	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—NRAS—thyroid cancer	5.62e-05	0.000929	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	5.54e-05	0.000916	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—KRAS—thyroid cancer	5.51e-05	0.00091	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—HPGD—thyroid cancer	5.35e-05	0.000884	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CHST14—thyroid cancer	5.3e-05	0.000876	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	5.16e-05	0.000853	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—MINPP1—thyroid cancer	5.11e-05	0.000845	CbGpPWpGaD
Nisoldipine—CACNA1S—Developmental Biology—AKT1—thyroid cancer	5.09e-05	0.000841	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—HRAS—thyroid cancer	4.94e-05	0.000817	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.91e-05	0.000812	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—KRAS—thyroid cancer	4.84e-05	0.0008	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—HRAS—thyroid cancer	4.68e-05	0.000774	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.66e-05	0.000771	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.5e-05	0.000744	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PPARG—thyroid cancer	4.39e-05	0.000726	CbGpPWpGaD
Nisoldipine—CACNB2—Developmental Biology—AKT1—thyroid cancer	4.36e-05	0.000721	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.35e-05	0.000719	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—HPGD—thyroid cancer	4.27e-05	0.000706	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—SLC5A5—thyroid cancer	4.22e-05	0.000697	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PPARG—thyroid cancer	4.16e-05	0.000687	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—AKT1—thyroid cancer	4.13e-05	0.000683	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.13e-05	0.000682	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—HRAS—thyroid cancer	4.11e-05	0.00068	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CHST14—thyroid cancer	4.09e-05	0.000676	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—TPR—thyroid cancer	4.07e-05	0.000673	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	4.01e-05	0.000662	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PPARG—thyroid cancer	3.65e-05	0.000604	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—AKT1—thyroid cancer	3.63e-05	0.0006	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—RXRA—thyroid cancer	3.54e-05	0.000586	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.46e-05	0.000573	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.46e-05	0.000571	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PTGS2—thyroid cancer	3.45e-05	0.000571	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—HPGD—thyroid cancer	3.3e-05	0.000545	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PTGS2—thyroid cancer	3.27e-05	0.000541	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—TPR—thyroid cancer	3.07e-05	0.000508	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.07e-05	0.000508	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—SLC5A5—thyroid cancer	3.05e-05	0.000504	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	3.02e-05	0.0005	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PTEN—thyroid cancer	3.01e-05	0.000498	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PTGS2—thyroid cancer	2.87e-05	0.000475	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PTEN—thyroid cancer	2.85e-05	0.000471	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.59e-05	0.000429	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—RXRA—thyroid cancer	2.56e-05	0.000423	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PTEN—thyroid cancer	2.51e-05	0.000414	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—TPR—thyroid cancer	2.45e-05	0.000405	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	2.41e-05	0.000399	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.3e-05	0.00038	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PPARG—thyroid cancer	2.24e-05	0.00037	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.19e-05	0.000362	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—RXRA—thyroid cancer	1.93e-05	0.000319	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—TPR—thyroid cancer	1.89e-05	0.000313	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.86e-05	0.000308	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.84e-05	0.000303	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.76e-05	0.000291	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—AKT1—thyroid cancer	1.74e-05	0.000287	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.72e-05	0.000284	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—AKT1—thyroid cancer	1.64e-05	0.000272	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PPARG—thyroid cancer	1.62e-05	0.000267	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—RXRA—thyroid cancer	1.54e-05	0.000255	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PTEN—thyroid cancer	1.53e-05	0.000254	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.5e-05	0.000248	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—AKT1—thyroid cancer	1.44e-05	0.000239	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.42e-05	0.000234	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.27e-05	0.00021	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PPARG—thyroid cancer	1.22e-05	0.000202	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—RXRA—thyroid cancer	1.19e-05	0.000197	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PTEN—thyroid cancer	1.11e-05	0.000183	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PPARG—thyroid cancer	9.74e-06	0.000161	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PTGS2—thyroid cancer	9.6e-06	0.000159	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—AKT1—thyroid cancer	8.84e-06	0.000146	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PTEN—thyroid cancer	8.37e-06	0.000138	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PTGS2—thyroid cancer	7.66e-06	0.000127	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PPARG—thyroid cancer	7.52e-06	0.000124	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PTEN—thyroid cancer	6.68e-06	0.00011	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—AKT1—thyroid cancer	6.39e-06	0.000106	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.91e-06	9.77e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PTEN—thyroid cancer	5.16e-06	8.52e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—AKT1—thyroid cancer	4.82e-06	7.97e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—AKT1—thyroid cancer	3.85e-06	6.37e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.97e-06	4.91e-05	CbGpPWpGaD
